ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質、抗体、アッセイキット

タンパク質カタログ

輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。

サプライヤー
TargteMol
カタログNo.
TMPY-00548
製品名称
HGFR/c-Met Protein, Cynomolgus, Rhesus, Recombinant (His)
タンパク質名
HGFR/c-Met
Species
Cynomolgus,Rhesus
HOST
HEK293 Cells
100μg: -
お問い合わせ

Overview

Synonyms MET proto-oncogene, receptor tyrosine kinase
Characteristics Measured by its binding ability in a functional ELISA. Immobilized Cynomolgus HGF at 2 μg/ml (100 μl/well) can bind Cynomolgus c-MET His , the EC50 of Cynomolgus c-MET His is 15-60 ng/mL.
Endotoxin Level < 1.0 EU/μg of the protein as determined by the LAL method.
Purity SDS-PAGE: 98.1%; SEC-HPLC: 98.5%
Description HGFR/c-Met Protein, Cynomolgus, Rhesus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 103.1 kDa and the accession number is G7MM61.
Reference Kong DS,et al.(2009) Prognostic significance of c-Met expression in glioblastomas. Cancer. 115(1): 140-8.,Socoteanu MP,et al.(2008) c-Met targeted therapy of cholangiocarcinoma. World J Gastroenterol. 14(19): 2990-4.,McGill GG,et al.(2006) c-Met expression is regulated by Mitf in the melanocyte lineage. J Biol Chem. 281(15): 10365-73.,Garcia S,et al.(2007) c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays. British journal of cancer. 96(2): 329-35.
URL https://www.targetmol.com/recombinant-protein/c_met_protein_cynomolgus_rhesus_recombinant_his_tag_hplc_verified

お問い合わせリスト(-)

お問い合わせフォーム